ProMIS Neurosciences Correlations

PMN Stock

USD 15.25 0.29 1.94%

The current 90-days correlation between ProMIS Neurosciences and Lipocine is -0.12 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

ProMIS Neurosciences Correlation With Market

Weak diversification

The correlation between ProMIS Neurosciences and DJI is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ProMIS Neurosciences and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with ProMIS Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.

Moving together with ProMIS Stock

0.73	CMB	Cambium Bio	Pair Corr
0.66	DNTH	Dianthus Therapeutics	Pair Corr
0.61	6C1	CytomX Therapeutics	Pair Corr
0.62	DRTS	Alpha Tau Medical	Pair Corr
0.69	PYC	Physiomics Plc	Pair Corr

Moving against ProMIS Stock

0.75	VCYT	Veracyte	Pair Corr
0.62	DRMA	Dermata Therapeutics	Pair Corr
0.6	OSE	OSE Pharma SA	Pair Corr
0.53	CDIOW	Cardio Diagnostics	Pair Corr
0.35	RAC	Race Oncology Earnings Call This Week	Pair Corr
0.35	DXB	Dimerix Earnings Call This Week	Pair Corr
0.76	VKTX	Viking Therapeutics	Pair Corr
0.75	BIM	Biomerieux SA	Pair Corr
0.71	DYAI	Dyadic International	Pair Corr
0.68	XE9	Xencor Inc	Pair Corr
0.64	XE7C	Cardiff Oncology	Pair Corr
0.58	VSTM	Verastem	Pair Corr
0.54	DTIL	Precision BioSciences	Pair Corr
0.42	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	MPLT	ERNA	OSRH	LPCN	ADAP	EDSA	ANL	GOVX	THAR	BRTX
MPLT		-0.07	0.01	0.14	0.06	-0.21	0.0	-0.22	-0.05	0.02	MPLT
ERNA	-0.07		0.3	-0.49	0.18	0.51	-0.5	0.62	-0.59	0.44	ERNA
OSRH	0.01	0.3		0.16	0.4	0.47	-0.53	-0.05	-0.47	0.43	OSRH
LPCN	0.14	-0.49	0.16		0.58	-0.48	0.33	-0.89	0.57	0.0	LPCN
ADAP	0.06	0.18	0.4	0.58		0.03	-0.27	-0.4	-0.12	0.32	ADAP
EDSA	-0.21	0.51	0.47	-0.48	0.03		-0.86	0.5	-0.78	0.59	EDSA
ANL	0.0	-0.5	-0.53	0.33	-0.27	-0.86		-0.3	0.87	-0.63	ANL
GOVX	-0.22	0.62	-0.05	-0.89	-0.4	0.5	-0.3		-0.54	-0.07	GOVX
THAR	-0.05	-0.59	-0.47	0.57	-0.12	-0.78	0.87	-0.54		-0.45	THAR
BRTX	0.02	0.44	0.43	0.0	0.32	0.59	-0.63	-0.07	-0.45		BRTX
	MPLT	ERNA	OSRH	LPCN	ADAP	EDSA	ANL	GOVX	THAR	BRTX

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

THAR	+ 0.87	ANL
GOVX	+ 0.62	ERNA
BRTX	+ 0.59	EDSA
ADAP	+ 0.58	LPCN
THAR	+ 0.57	LPCN
EDSA	+ 0.51	ERNA

High negative correlations

GOVX	- 0.89	LPCN
ANL	- 0.86	EDSA
THAR	- 0.78	EDSA
BRTX	- 0.63	ANL
THAR	- 0.59	ERNA
THAR	- 0.54	GOVX

Risk-Adjusted Indicators

There is a big difference between ProMIS Stock performing well and ProMIS Neurosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProMIS Neurosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MPLT	3.94	0.43	0.08	(0.61)	4.02	(4.92)	8.28	(7.08)	39.27
ERNA	5.53	(1.96)	0.00	1.98	0.00	0.00	12.10	(18.42)	59.74
OSRH	6.19	0.24	0.03	0.85	6.41	(7.95)	14.04	(10.77)	43.23
LPCN	4.80	1.89	0.39	(6.27)	3.17	(5.81)	15.95	(7.33)	33.09
ADAP	12.64	0.42	0.03	0.22	15.04	(16.63)	22.82	(18.18)	168.52
EDSA	2.82	(0.71)	0.00	0.95	0.00	0.00	4.14	(6.54)	20.23
ANL	8.96	3.93	0.52	(3.76)	5.54	(11.85)	25.00	(12.79)	100.98
GOVX	5.87	(2.79)	0.00	(0.94)	0.00	0.00	9.38	(13.98)	42.89
THAR	5.23	0.39	0.07	0.28	5.59	(5.89)	11.15	(9.64)	29.73
BRTX	5.05	(1.82)	0.00	0.97	0.00	0.00	6.36	(22.38)	54.37

ProMIS Neurosciences Corporate Management

Gail Farfel	Chief Officer	Profile
Daniel MBA	Chief Officer	Profile
Johanne Kaplan	Chief Officer	Profile
Dennis Chen	Head Consultant	Profile
David Wishart	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC